Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
100244301----1件: 274 💬
2[AMG 162]----1件: 274 💬
3[AMG 785]----1件: 274 💬
4[vitamina D e calcio]1件: Calcium---1件: 274 💬
5Aclasta----4件: 13, 97, 271, 274 💬
6Actonel 5mg Film Coated Tablets----1件: 274 💬
7Actonel Once a Week 35 mg film-coated tablets----1件: 274 💬
8Actonel/Optinate 5mg film-coated tablets----1件: 274 💬
9AGA21151件: AGA2115---1件: 274 💬
10Alendronate----4件: 46, 271, 274, 299 💬
11ALENDRONIC ACID1件: Alendronic acid2件: Alendronate sodium ,
Alendronic acid 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬2件: 46, 274 💬
12Alternative osteoporosis medications----1件: 274 💬
13AMG 162----1件: 274 💬
14AMG 785----1件: 274 💬
15ANTI-SCLEROSTIN MONOCLONAL ANTIBODY----1件: 274 💬
16Bisphosphonate----1件: 274 💬
17Bisphosphonates----2件: 6, 274 💬
18Blood sample----33件: 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
19Bone Marrow Transplant----2件: 60, 274 💬
20Bone marrow-derived mesenchymal stromal cells (MSCs)----1件: 274 💬
21Bonefos----1件: 274 💬
22BOOST cells----1件: 274 💬
23BPS804----2件: 172, 274 💬
24BPS804, UX143----1件: 274 💬
25Busulfan1件: Busulfan1件: Busulfan 💬 --14件: 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
26Calcichew D3----1件: 274 💬
27Calcichew tablets----1件: 274 💬
28CALCIO CARBONATO/COLECALCIFEROLO1件: Calcium---1件: 274 💬
29Calcium1件: Calcium---39件: 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
30Calcium D31件: Calcium---1件: 274 💬
31CALCIUM D3 SANDOZ - 1000 MG + 880 U.I. COMPRESSE EFFERVESCENTI 30 COMPRESSE DIVISIBILI1件: Calcium---1件: 274 💬
32Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida----1件: 274 💬
33Clasteon----1件: 274 💬
34Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
35Cyclosporin----6件: 53, 60, 97, 222, 223, 274 💬
36Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas----1件: 274 💬
37Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada PEI nº 12-088)----1件: 274 💬
38Denosumab1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬11件: 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬
39Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
40Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬1件: 274 💬
41Denusomab----1件: 274 💬
42Disodium Pamidronate 15mg (15mg strength)----1件: 274 💬
43Evenity 105mg----1件: 274 💬
44Expanded human first trimester fetal liver-derived mesenchymal stem cells----1件: 274 💬
45Forsteo----3件: 70, 235, 274 💬
46Fresolimumab1件: Fresolimumab1件: Fresolimumab 💬 3件: TGFB1,
TGFB2,
TGFB3 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬3件: 51, 222, 274 💬
47Fultium-D3 800IU capsules----1件: 274 💬
48GENOTROPIN*1TBF 5,3MG (16UI)----1件: 274 💬
49H05AA02----1件: 274 💬
50High-dose vitamin D (2000 IU per day)1件: Vitamin D---1件: 274 💬
51Humatrope----1件: 274 💬
52Ibandronic acid----1件: 274 💬
53Manual cuff blood pressure----1件: 274 💬
54Mesenchymal stem cell transplantation----2件: 36, 274 💬
55Mesenchymal stem cells----16件: 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 107, 222, 271, 274, 298, 299 💬
56Mesenchymal stromal cells----7件: 36, 51, 96, 97, 107, 274, 284 💬
57NERIXIA*INFUS IV CONC 2F 100MG----1件: 274 💬
58Optinate 5 mg filmcoated tablets----1件: 274 💬
59Other: Blood flow restriction training----3件: 6, 149, 274 💬
60Other: Bone Marrow Cell Transplantation----1件: 274 💬
61Other: No active treatment----1件: 274 💬
62Other: No treatment----2件: 53, 274 💬
63Other: Saline----8件: 2, 6, 46, 97, 98, 256, 274, 301 💬
64Pamidronate----3件: 270, 271, 274 💬
65Pamidronate (Aredia)----1件: 274 💬
66Pamidronate Disodium1件: Pamidronic acid2件: Pamidronate disodium ,
Pamidronic acid 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
67PLASMASAFE----1件: 274 💬
68PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML----1件: 274 💬
69Prolia----1件: 274 💬
70Radiation: Irradiation, Total Body----1件: 274 💬
71REF CRUZADA PEI Nº 12-088----1件: 274 💬
72Risedronate Oral Tablet----1件: 274 💬
73Risedronate sodium1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬5件: 46, 50, 107, 113, 274 💬
74Risedronate sodium (Actonel)1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
75Risedronate sodium 2.5mg1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
76Risedronate sodium 5mg1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
77Risedronato sódico 2.5mg----1件: 274 💬
78Risedronato sódico 5mg----1件: 274 💬
79Risedronic acid1件: Risedronic acid3件: Risedronate sodium ,
Risedronic acid ,
Risedronate sodium monohydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬3件: 93, 95, 274 💬
80RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
81Romosozumab1件: Romosozumab1件: Romosozumab 💬 1件: SOST 💬 2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬2件: 46, 274 💬
82SAR439459----1件: 274 💬
83SETRUSUMAB1件: Setrusumab1件: Setrusumab 💬 1件: SOST 💬 2件: Parathyroid hormone synthesis, secretion and action, Wnt signaling pathway 💬1件: 274 💬
84SetrusumabProduct Code: BPS804, UX143Pharmaceutical Form: Lyophilisate for solution for infusionINN or Proposed INN: SETRUSUMABCAS Number: 1847394-95-9Other descriptive name: UX143, BPS804Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 160-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use----1件: 274 💬
85Somatropin----14件: 3, 74, 75, 78, 97, 107, 113, 187, 193, 195, 222, 238, 274, 276 💬
86Standard-dose vitamin D (400IU per day)1件: Vitamin D---1件: 274 💬
87Teriparatide1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬7件: 46, 68, 70, 71, 172, 235, 274 💬
88Teriparatide (FORTEO)1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 274 💬
89Teriparatide Pen Injector1件: Teriparatide3件: Teriparatide acetate ,
Teriparatide ,
Teriparatide acetate 💬 		1件: PTH1R 💬 4件: Endocrine and other factor-regulated calcium reabsorption, Hormone signaling, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 274 💬
90Tranexamic acid1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬7件: 46, 65, 70, 215, 227, 274, 299 💬
91UX143, BPS804----1件: 274 💬
92VARI----2件: 62, 274 💬
93Vitamin D1件: Vitamin D---26件: 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
94Water1件: Water1件: Water 💬 --36件: 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
95XGEVA----1件: 274 💬
96XGEVA - 120 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 1.7 ML 4 FLACONCINI----1件: 274 💬
97ZOL446----2件: 97, 274 💬
98Zoledronic acid1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬16件: 5, 6, 13, 17, 46, 75, 77, 93, 95, 96, 97, 270, 274, 282, 299, 333 💬
99Zoledronic acid (optional)1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
100Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion, generic medicinal product1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
101Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion, generic medicinal product.1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
102Zoledronic Acid Kern Pharma 4 mg/100 mL solution for infusion,generic medicinal product1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬1件: 274 💬
103Zometa----1件: 274 💬
104Ácido risedrónico----1件: 274 💬